← Open Payments lookup

IDALISSIE PEGUERO: Open Payments

NPI 1689154437 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$759 in 30 payments from 10 companies in 2025. Trend: 2023 $125 · 2024 $615 · 2025 $759

Food & beverage: $759
CompanyPaymentsAmount
Alkermes, Inc.8$344
Neurocrine BioSciences, Inc.6$107
Otsuka America Pharmaceutical, Inc.5$94
Teva Pharmaceuticals USA, Inc.4$70
E.R. Squibb & Sons, L.L.C.1$39
Vanda Pharmaceuticals Inc.2$34
Lundbeck LLC1$20
Janssen Pharmaceuticals, Inc1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
Almatica Pharma LLC1$15

Products named: LYBALVI, INGREZZA, ARISTADA, REXULTI, COBENFY, AUSTEDO XR, VIVITROL, FANAPT.

Industry payments across NJ — which companies pay providers there.